Skip to content

Comparison between tramadol and diclofenac for pain relief in case of acute pancreatitis

A randomized controlled trial to compare between tramadol and diclofenac for achieving analgesia in patients of acute pancreatitis. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080121
Enrollment
74
Registered
2025-02-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K859- Acute pancreatitis, unspecified

Interventions

Intervention1: injection Fentanyl: injection Fentanyl will be used as rescue analgesia in both group of patient receiving either tramadol or diclofenac and will be delivered by intravenous route throu

Sponsors

IPGMER AND SSKM
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of acute pancreatitis diagnosed as per revised Atlanta classification with two out of the following three points 1. abdominal pain consistent with acute pancreatitis 2. Serum lipase or amylase activity at least three times greater than upper limit of normal 3. Characteristics imaging finding on trans abdominal ultrasound or contrast enhanced computed tomography of abdomen or magnetic resonance imaging of pancreas. The patient diagnosed as acute pancreatitis should be 1.present with in 7 day of pain onset 2.presents with pain abdomen with visual analogue score 3 or more and 3. normal sensorium as defined by Glasgow coma score 15.

Exclusion criteria

Exclusion criteria: Age less than 18 and more than 75. Patient with evidence of chronic pancreatitis. Patient with shock requiring vasopressor. Patient with respiratory failure requiring mechanical ventilation. Patient with serum creatinine more than equal to 1.5 mg per dl. Patient with coronary artery disease. Patient with altered sensorium with Glasgow coma scale less than 15. Patient refuses to give consent.

Design outcomes

Primary

MeasureTime frame
To measure the difference in efficacy of tramadol and diclofenac in pain relief in patients of acute pancreatitis.Timepoint: 40 hours and 3 days of follow up

Secondary

MeasureTime frame
To measure the difference in the adverse events between the diclofenac and tramadol group. Timepoint: 3 days of follow up

Countries

India

Contacts

Public ContactDR DEBASHIS MISRA

IPGMER AND SSKM

debcnmch@yahoo.com9830472292

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026